SIREN : 892668336
LAZEO MEDICAL VAL D'EUROPE is a French company founded 5 years ago, specialized in the sector Soins de beauté. Based in CHESSY (77700), this company of category ETI shows in 2023 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | N/C | 1 172 631 € | 1 390 967 € | 786 377 € |
| Net income | -100 106 € | 61 152 € | 279 246 € | 83 506 € |
| EBITDA | N/C | 126 248 € | 407 528 € | 163 908 € |
| Net margin | N/C | 5.2% | 20.1% | 10.6% |
In 2024, LAZEO MEDICAL VAL D'EUROPE records a net loss of 100 k€. This deficit will reduce equity on the balance sheet.
-100 106 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory.
0.0%
27.258%
52.4%
In 2024, the debt ratio of LAZEO MEDICAL VAL D'EUROPE (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of LAZEO MEDICAL VAL D'EUROPE (27.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2023, the repayment capacity of LAZEO MEDICAL VAL D'EUROPE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 120.24. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
120.239
In 2024, the liquidity ratio of LAZEO MEDICAL VAL D'EUROPE (120.24) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of LAZEO MEDICAL VAL D'EUROPE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Compare LAZEO MEDICAL VAL D'EUROPE with other companies in the same sector:
The revenue of LAZEO MEDICAL VAL D'EUROPE in 2023 is 1.2 M€.
LAZEO MEDICAL VAL D'EUROPE recorded a net loss in 2024.
The headquarters of LAZEO MEDICAL VAL D'EUROPE is located in CHESSY (77700), in the department Seine-et-Marne.
The tax return of LAZEO MEDICAL VAL D'EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAZEO MEDICAL VAL D'EUROPE operates in the sector Soins de beauté (NAF code 96.02B). See the 'Sector positioning' section above to compare the company with its competitors.